1. Home
  2. CDNA vs ETG Comparison

CDNA vs ETG Comparison

Compare CDNA & ETG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$28.90

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Eaton Vance Tax-Advantaged Global Dividend Income Fund of Beneficial Interest

ETG

Eaton Vance Tax-Advantaged Global Dividend Income Fund of Beneficial Interest

HOLD

Current Price

$23.38

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDNA
ETG
Founded
1998
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.8B
IPO Year
2007
2003

Fundamental Metrics

Financial Performance
Metric
CDNA
ETG
Price
$28.90
$23.38
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$28.00
N/A
AVG Volume (30 Days)
932.9K
95.2K
Earning Date
04-28-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
$48,324,000.00
N/A
Revenue This Year
$16.01
N/A
Revenue Next Year
$11.31
N/A
P/E Ratio
$582.20
N/A
Revenue Growth
18.93
N/A
52 Week Low
$10.96
$19.34
52 Week High
$30.00
$23.76

Technical Indicators

Market Signals
Indicator
CDNA
ETG
Relative Strength Index (RSI) 65.45 56.05
Support Level $14.59 $22.70
Resistance Level N/A $23.44
Average True Range (ATR) 1.40 0.34
MACD 0.01 0.02
Stochastic Oscillator 85.34 68.64

Price Performance

Historical Comparison
CDNA
ETG

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About ETG Eaton Vance Tax-Advantaged Global Dividend Income Fund of Beneficial Interest

Eaton Vance Tax Advgd Gbl Div Inc Fd is a diversified, closed-end management investment company. Its investment objective is to provide a high level of after-tax total return consisting of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. Its portfolio of investments consists of aerospace and defense, capital markets, diversified telecommunication services, electrical equipment, biotechnology, banks, and other areas.

Share on Social Networks: